China Pharma Market 2025
Uneven Gains, Mounting Risks: Tough Road Ahead for Pharma Giants in China
China Pharma H1 2025: AstraZeneca, Roche, Novo & Lilly lead via oncology & GLP-1 hits; Merck, Sanofi & Pfizer struggle with rivals, VBP & patents. Multichannel + partnerships key.